Skip to main content
SpringerLink
Log in

Electrochemotherapy for Colorectal Cancer with Commonly Used Chemotherapeutic Agents in a Mouse Model

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

We examined here the usefulness of electrochemotherapy against colorectal cancer (CRC) using a mouse model. Electropermeabilization profoundly increased the sensitivity of murine CRC, Colon 26, and MC38 cells to bleomycin (BLM) but not to 5-fluorouracil (5-FU) or to cisplatin (CDDP) in vitro. In vivo experiments revealed that electrochemotherapy with 5-FU, CDDP, or BLM was much more effective against CRC compared with the treatment of the drug alone. Electrochemotherapy with BLM or CDDP exhibited profound antitumor effects on subcutaneously established CRC in mice, and complete tumor regression was observed in five and four of eight animals, respectively. Electrochemotherapy with 5-FU also had an impact on CRC development, and complete cure was observed in one of eight animals. Subsequent analyses revealed that electropermeabilization significantly increased intratumoral amounts of BLM and CDDP but not 5-FU. These results indicate that electrochemotherapy may be a promising treatment modality against CRC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

REFERENCES

  1. Parkin DM, Pisani P, Ferlay J: Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606, 1993

    Google Scholar 

  2. Finkelstein SD, Sayegh R, Christensen S, Swalsky PA: Genotypic classification of colorectal adenocarcinoma. Cancer 71:3827–3838, 1993

    Google Scholar 

  3. Boyle P, Zaridze DG, Smans M: Descriptive epidemiology of colorectal cancer. Int J Cancer 36:9–18, 1985

    Google Scholar 

  4. Langman M, Boyle P: Chemoprevention of colorectal cancer. Gut 43:578–585, 1998

    Google Scholar 

  5. Pisani P, Parkin DM, Ferlay J: Estimates of the worldwide mortality rate from 18 major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891–903, 1993

    Google Scholar 

  6. Cortesi E, Padovani A, Aloe A, Picece V, Pellegrini P, Pellegrini A: Advanced colorectal cancer: Impact of chemotherapy on survival. J Surg Oncol 48(suppl 2):112–115, 1991

    Google Scholar 

  7. Midgley R, Kerr D: Colorectal cancer. Lancet 353:391–399, 1999

    Google Scholar 

  8. Cao G, Kuriyama S, Gao J, Mitoro A, Cui L, Nakatani T, Zhang X, Kikukawa M, Pan X, Fukui H, Qi Z: Comparison of carcinoembryonic antigen promoter regions isolated from human colorectal carcinoma and normal adjacent mucosa to induce strong tumor-selective gene expression. Int J Cancer 78:242–247, 1998

    Google Scholar 

  9. Cao G, Kuriyama S, Gao J, Kikukawa M, Cui L, Nakatani T, Zhang X, Tsujinoue H, Pan X, Fukui H, Qi Z: Effective and safe gene therapy for colorectal carcinoma using the cytosine deaminase gene directed by the carcinoembryonic antigen promoter. Gene Ther 6:83–90, 1999

    Google Scholar 

  10. Cao G, Kuriyama S, Cui L, Nagao S, Pan X, Toyokawa Y, Zhang X, Nishiwaki I, Qi Z: Analysis of the human carcinoembryonic antigen promoter core region in colorectal carcinoma-selective cytosine deaminase gene therapy. Cancer Gene Ther (in press)

  11. Cao G, Kuriyama S, Gao J, Mitoro A, Cui L, Nagao S, Zhang X, Tsujinoue H, Pan X, Fukui H, Qi Z: In vivo gene transfer of a suicide gene under the transcriptional control of the carcinoembryonic antigen promoter results in bone marrow transduction but can avoid bone marrow suppression. Int J Oncol 15:107–112, 1999

    Google Scholar 

  12. Mir LM, Orlowski S, Belehradek J Jr, Paoletti C: Electrochemotherapy potentiation of antitumor effect of bleomycin by local electric pulses. Eur J Cancer 2</del>7:68–72, 1991

    Google Scholar 

  13. Rols MP, Teissie J: Electropermeabilization of mammalian cells. Quantitative analysis of the phenomenon. Biophys J 58:1089–1098, 1990

    Google Scholar 

  14. Melvik JE, Pattersen EO, Gordon PB, Selgen PO: Increase cis-dichlorodiammineplatinum(II) cytotoxicity upon reversible electropermeabilization of the plasma membrane in cultured human NHIK 3025 cells. Eur J Cancer Clin Oncol 22:1523–1530, 1986

    Google Scholar 

  15. Orlowski S, Belehradek J Jr, Paolett C, Mir LM: Transient electropermeabilization of cells in culture. Biochem Pharmacol 37:4727–4733, 1988

    Google Scholar 

  16. Poddevin B, Orlowski S, Belehradek J Jr, Mir LM: Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42:S67–S75, 1991

    Google Scholar 

  17. Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM: Electrochemotherapy, a new antitumor treatment. First clinical phase I-II trial. Cancer 72:3694–3700, 1993

    Google Scholar 

  18. Rudolf Z, Stabuc B, Cemazar M, Miklavcic D, Vodovnik L, Sersa G: Electrochemotherapy with bleomycin: The first clinical experience in malignant melanoma patients. Radiol Oncol 29:229–235, 1995

    Google Scholar 

  19. Domenge C, Orlowski S, Luboinski B, Debaere T, Schwaab G, Belehradek J Jr, Mir LM: Antitumor electrochemotherapy. New advances in the clinical protocol. Cancer 77:956–963, 1996

    Google Scholar 

  20. Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rappaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS: Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964–971, 1996

    Google Scholar 

  21. Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM: Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 27:73–76, 1991

    Google Scholar 

  22. Mir LM, Orlowski S, Poddevin B, Belehradek J Jr: Electrochemotherapy tumor treatment is improved by interleukin-2 stimulation of the host' defenses. Eur Cytokine Netw 3:331–334, 1992

    Google Scholar 

  23. Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek J Jr, Kourilsky P: Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 17:30–38, 1995

    Google Scholar 

  24. Okino M, Tomie H, Kanesada H, Marumoto M, Esato K, Suzuki H: Optimal electric conditions in electrical impulse chemotherapy. Jpn J Cancer Res 83:1095–1101, 1992

    Google Scholar 

  25. Salford LG, Persson BRR, Brun A, Ceberg CP, Kongstad PC, Mir LM: A new brain tumour therapy combining bleomycin with in vivo electropermeabilization. Biochem Biophys Res Commun 194:938–943, 1993

    Google Scholar 

  26. Tsuruo T, Yamori T, Naganuma K, Tsukagoshi S, Sakurai Y: Characterization of metastatic clones derived from a metastatic variant of mouse colon adenocarcinoma 26. Cancer Res 43:5437–5442, 1983

    Google Scholar 

  27. Mullen CA, Coale MM, Lowe R, Blaese RM: Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5–fluorocytosine and induce protective immunity to wild type tumor. Cancer Res 54:1503–1506, 1994

    Google Scholar 

  28. Kuriyama S, Nakatani T, Masui K, Sakamoto T, Tominaga K, Yoshikawa M, Fukui H, Ikenaka K, Tsujii T: Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma. Hepatology 22:1838–1846, 1995

    Google Scholar 

  29. Marquardt DW, Siam J: An algorithum for least square estimation of non-linear parameters. J Soc Ind Appl Math 11:431–441, 1963

    Google Scholar 

  30. Kuriyama S, Masui K, Sakamoto T, Nakatani T, Kikukawa M, Tsujinoue H, Mitoro A, Yamazaki M, Yoshiji H, Fukui H, Ikenaka K, Mullen CA, Tsujii T: Bystander effect caused by cytosine deaminase gene and 5–fluorocytosine in vitro is substantially mediated by generated 5–fluorouracil. Anticancer Res 18:3399–3406, 1998

    Google Scholar 

  31. Riley CM, Sternson LA, Repta AJ: Assessment of cisplatin reacting with peptides and proteins using reverse-phase high performance liquid chromatography and flameless atomic absorption spectroscopy. Anal Biochem 124:167–179, 1982

    Google Scholar 

  32. Ohnuma T, Holland JF, Masuda H, Waligunda JA, Goldberg GA: Microbiological assay of bleomycin: inactivation, tissue distribution, and clearance. Cancer 33:1230–1238, 1974

    Google Scholar 

  33. Huber BE, Austin EA, Good SS, Knick VC, Tibbels KS, Richards CA: In vivo antitumor activity of 5–fluorocytosine in human colorectal tumor cells transduced with the cytosine deaminase gene: Significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. Proc Natl Acad Sci USA 91:8302–8306, 1994

    Google Scholar 

  34. Kuriyama S, Masui K, Sakamoto T, Nakatani T, Tominaga K, Fukui H, Ikenaka K, Mullen CA, Tsujii T: Bacterial cytosine deaminase suicide gene transduction renders hepatocellular carcinoma sensitive to the prodrug 5–fluorocytosine. Int Hepatol Commun 4:72–79, 1995

    Google Scholar 

  35. Kuriyama S, Kikukawa M, Masui K, Okuda H, Nakatani T, Sakamoto T, Yoshiji H, Fukui H, Ikenaka K, Mullen CA, Tsujii T: Cytosine deaminase/5–fluorocytosine gene therapy can induce efficient anti-tumor effects and protective immunity in immunocompetent mice but not in athymic nude mice. Int J Cancer 81:592–597, 1999

    Google Scholar 

  36. Gately DP, Howell SB: Cellular accumulation of the anticancer agent cisplatin: A review. Br J Cancer 67:1171–1176, 1993

    Google Scholar 

  37. Jekunen AP, Shalinsky DR, Hom DK, Albright KD, Heath D, Howell SB: Modulation of cisplatin cytotoxicity by permeabilization of the plasma membrane by digitonin in vitro. Biochem Pharmacol 45:2079–2085, 1993

    Google Scholar 

  38. Melvik JE, Dornish JM, Pettersen EO: The binding of cisdichlorodiammineplatinum( II) to extracellular and intracellular compounds in relation to drug uptake and cytotoxicity in vitro. Br J Cancer 66:260–265, 1992

    Google Scholar 

  39. Nutt AK, Mansouri A, Henle KJ: Response of cisplatin resistant tumor cells to electroporation and cisplatin. Proc Annu Meet Am Assoc Cancer Res 32:375, 1991

    Google Scholar 

  40. Sersa G, Cemazar M, Miklavcic D: Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum(II) in mice. Cancer Res 55:3450–3455, 1995

    Google Scholar 

  41. Umezawa H, Maeda K, Takeuchi T, Okami Y: New antibiotics bleomycin A and B. J Antibiot 19A:200–209, 1966

    Google Scholar 

  42. Mir LM, Tounekti O, Orlowski S: Bleomycin: Revival of an old drug. Gen Pharmacol 27:745–748, 1996

    Google Scholar 

  43. Sidik K, Smerdon MJ: Bleomycin-induced DNA damage and repair in human cells permeabilized with lysophosphatidylcholine. Cancer Res 50:1613–1619, 1990

    Google Scholar 

  44. Natsugoe S, Shimada M, Kumanohoso T, Tokuda K, Baba M, Yoshinaka H, Fukumoto T, Nakamura K, Yamada K, Nakashima T: Enhanced efficacy of bleomycin adsorbed on silica particles against lymph node metastasis in patients with esophageal cancer: A pilot study. Surgery 117:636–641, 1995

    Google Scholar 

  45. Kambe M, Arita D, Kikuchi H, Funato T, Tezuka F, Gamo M, Murakawa Y, Kanamaru R: Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation. Tohoku J Exp Med 180:161–171, 1996

    Google Scholar 

  46. Tada T, Matsumoto K, Suzuki H: Electrochemotherapy significantly inhibits the growth of colon 26 tumors in mice. Surg Today 27:506–510, 1997

    Google Scholar 

  47. Mitoro A, Kuriyama S, Tsujinoue H, Matsumoto M, Nakatani T, Fukui H: Electrochemotherapy with bleomycin against colorectal carcinoma in a mouse model: Evaluations of the dose and administration route of the drug and the electric field intensity. Int J Oncol (in press)

  48. Kuriyama S, Kikukawa M, Mitoro A, Tsujinoue H, Nakatani T, Yamazaki M, Yoshiji H, Toyokawa Y, Yoshikawa M, Fukui H: Antitumor effect of electrochemotherapy on colorectal carcinoma in an orthotopic mouse model. Int J Oncol 14:321–326, 1999

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Third Department of Internal Medicine, Nara Medical University, Kashihara, Nara, 634-8522, Japan

    Shigeki Kuriyama, Mototsugu Matsumoto, Akira Mitoro, Hirohisa Tsujinoue, Toshiya Nakatani, Hiroshi Fukui & Tadasu Tsujii

Authors
  1. Shigeki Kuriyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mototsugu Matsumoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Akira Mitoro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hirohisa Tsujinoue
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Toshiya Nakatani
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Hiroshi Fukui
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Tadasu Tsujii
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuriyama, S., Matsumoto, M., Mitoro, A. et al. Electrochemotherapy for Colorectal Cancer with Commonly Used Chemotherapeutic Agents in a Mouse Model. Dig Dis Sci 45, 1568–1577 (2000). https://doi.org/10.1023/A:1005565027969

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1005565027969

Search

Navigation